For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Adicet Bio Inc (NASDAQ: ACET) was $0.82 for the day, up 8.56% from the previous closing price of $0.75. In other words, the price has increased by $8.56 from its previous closing price. On the day, 0.46 million shares were traded. ACET stock price reached its highest trading level at $0.8197 during the session, while it also had its lowest trading level at $0.76.
Ratios:
Our analysis of ACET’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 9.34 and its Current Ratio is at 9.34. In the meantime, Its Debt-to-Equity ratio is 0.10 whereas as Long-Term Debt/Eq ratio is at 0.08.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACET now has a Market Capitalization of 67524120 and an Enterprise Value of -66669864.
Stock Price History:
The Beta on a monthly basis for ACET is 1.60, which has changed by -0.45960265 over the last 52 weeks, in comparison to a change of 0.17774606 over the same period for the S&P500. Over the past 52 weeks, ACET has reached a high of $1.70, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is 14.46%, while the 200-Day Moving Average is calculated to be -8.58%.
Shares Statistics:
ACET traded an average of 490.00K shares per day over the past three months and 342470 shares per day over the past ten days. A total of 82.71M shares are outstanding, with a floating share count of 65.35M. Insiders hold about 20.99% of the company’s shares, while institutions hold 49.08% stake in the company. Shares short for ACET as of 1751241600 were 3316444 with a Short Ratio of 6.77, compared to 1748563200 on 3125216. Therefore, it implies a Short% of Shares Outstanding of 3316444 and a Short% of Float of 5.3600002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current assessment of Adicet Bio Inc (ACET) involves the perspectives of 6.0 analysts closely monitoring its market dynamics.The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.22 and low estimates of -$0.33.
Analysts are recommending an EPS of between -$0.96 and -$1.31 for the fiscal current year, implying an average EPS of -$1.16. EPS for the following year is -$1.03, with 6.0 analysts recommending between -$0.73 and -$1.41.
